DIAGNOSE NEURODEGENERATIVER KRANKHEITEN
The invention relates to a method of diagnosis of vCJD in a diagnostic sample of a valid body tissue taken from a human subject, which comprises detecting an increased concentration of a protein in the diagnostic sample, compared with a sample of a control human subject, the protein being: beta-acti...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | ger |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | JACKSON, GRAHAM STUART COLLINGE, JOHN MCGREGOR, EMMA WESTBROOK, JULES BYERS, HELEN LEEDS, NICOLA LOUISE CAMPBELL, JAMES WARD, MALCOLM ANDREW |
| description | The invention relates to a method of diagnosis of vCJD in a diagnostic sample of a valid body tissue taken from a human subject, which comprises detecting an increased concentration of a protein in the diagnostic sample, compared with a sample of a control human subject, the protein being: beta-actin (SwissProt Acc. No. P60709), apolipoprotein A-IV precursor (SwissProt Acc. No. P06727); haptoglobin beta-chain consisting of residues 162-406 (SwissProt Acc. No. P00738); haemoglobin beta chain (SwissProt Acc. No. P02023); or alpha-1-antitrypsin (SwissProt Acc. No. P01009); or a decreased concentration of a protein in the diagnostic sample, compared with a sample of a control, normal human subject, the protein being plasma protease (C1) inhibitor precursor (SwissProt Acc. No. P05155); complement component 1, s sub-component (SwissProt Acc. No. P09871); butyrylcholinesterase precursor (SwissProt Acc. No. P06276); complement component C4B (SwissProt Acc. No. P01028); lumican (SwissProt Acc. No. P51884); alpha-fibrinogen precursor (SwissProt Acc. No. P02671); IGHG4 protein (Swiss Prot Acc. No. Q8TC63) or immunoglobulin lambda heavy chain. Other marker proteins are also disclosed. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ATE471519TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ATE471519TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ATE471519TT13</originalsourceid><addsrcrecordid>eNrjZFB38XR09_MPdlXwcw0N8ndxdXf1cw1yDPEMcw1S8A5y9PP2cPUMcfXjYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxjiGuJuaGpoaWISGGxsSoAQASFySy</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DIAGNOSE NEURODEGENERATIVER KRANKHEITEN</title><source>esp@cenet</source><creator>JACKSON, GRAHAM STUART ; COLLINGE, JOHN ; MCGREGOR, EMMA ; WESTBROOK, JULES ; BYERS, HELEN ; LEEDS, NICOLA LOUISE ; CAMPBELL, JAMES ; WARD, MALCOLM ANDREW</creator><creatorcontrib>JACKSON, GRAHAM STUART ; COLLINGE, JOHN ; MCGREGOR, EMMA ; WESTBROOK, JULES ; BYERS, HELEN ; LEEDS, NICOLA LOUISE ; CAMPBELL, JAMES ; WARD, MALCOLM ANDREW</creatorcontrib><description>The invention relates to a method of diagnosis of vCJD in a diagnostic sample of a valid body tissue taken from a human subject, which comprises detecting an increased concentration of a protein in the diagnostic sample, compared with a sample of a control human subject, the protein being: beta-actin (SwissProt Acc. No. P60709), apolipoprotein A-IV precursor (SwissProt Acc. No. P06727); haptoglobin beta-chain consisting of residues 162-406 (SwissProt Acc. No. P00738); haemoglobin beta chain (SwissProt Acc. No. P02023); or alpha-1-antitrypsin (SwissProt Acc. No. P01009); or a decreased concentration of a protein in the diagnostic sample, compared with a sample of a control, normal human subject, the protein being plasma protease (C1) inhibitor precursor (SwissProt Acc. No. P05155); complement component 1, s sub-component (SwissProt Acc. No. P09871); butyrylcholinesterase precursor (SwissProt Acc. No. P06276); complement component C4B (SwissProt Acc. No. P01028); lumican (SwissProt Acc. No. P51884); alpha-fibrinogen precursor (SwissProt Acc. No. P02671); IGHG4 protein (Swiss Prot Acc. No. Q8TC63) or immunoglobulin lambda heavy chain. Other marker proteins are also disclosed.</description><language>ger</language><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100715&DB=EPODOC&CC=AT&NR=E471519T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100715&DB=EPODOC&CC=AT&NR=E471519T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JACKSON, GRAHAM STUART</creatorcontrib><creatorcontrib>COLLINGE, JOHN</creatorcontrib><creatorcontrib>MCGREGOR, EMMA</creatorcontrib><creatorcontrib>WESTBROOK, JULES</creatorcontrib><creatorcontrib>BYERS, HELEN</creatorcontrib><creatorcontrib>LEEDS, NICOLA LOUISE</creatorcontrib><creatorcontrib>CAMPBELL, JAMES</creatorcontrib><creatorcontrib>WARD, MALCOLM ANDREW</creatorcontrib><title>DIAGNOSE NEURODEGENERATIVER KRANKHEITEN</title><description>The invention relates to a method of diagnosis of vCJD in a diagnostic sample of a valid body tissue taken from a human subject, which comprises detecting an increased concentration of a protein in the diagnostic sample, compared with a sample of a control human subject, the protein being: beta-actin (SwissProt Acc. No. P60709), apolipoprotein A-IV precursor (SwissProt Acc. No. P06727); haptoglobin beta-chain consisting of residues 162-406 (SwissProt Acc. No. P00738); haemoglobin beta chain (SwissProt Acc. No. P02023); or alpha-1-antitrypsin (SwissProt Acc. No. P01009); or a decreased concentration of a protein in the diagnostic sample, compared with a sample of a control, normal human subject, the protein being plasma protease (C1) inhibitor precursor (SwissProt Acc. No. P05155); complement component 1, s sub-component (SwissProt Acc. No. P09871); butyrylcholinesterase precursor (SwissProt Acc. No. P06276); complement component C4B (SwissProt Acc. No. P01028); lumican (SwissProt Acc. No. P51884); alpha-fibrinogen precursor (SwissProt Acc. No. P02671); IGHG4 protein (Swiss Prot Acc. No. Q8TC63) or immunoglobulin lambda heavy chain. Other marker proteins are also disclosed.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFB38XR09_MPdlXwcw0N8ndxdXf1cw1yDPEMcw1S8A5y9PP2cPUMcfXjYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxjiGuJuaGpoaWISGGxsSoAQASFySy</recordid><startdate>20100715</startdate><enddate>20100715</enddate><creator>JACKSON, GRAHAM STUART</creator><creator>COLLINGE, JOHN</creator><creator>MCGREGOR, EMMA</creator><creator>WESTBROOK, JULES</creator><creator>BYERS, HELEN</creator><creator>LEEDS, NICOLA LOUISE</creator><creator>CAMPBELL, JAMES</creator><creator>WARD, MALCOLM ANDREW</creator><scope>EVB</scope></search><sort><creationdate>20100715</creationdate><title>DIAGNOSE NEURODEGENERATIVER KRANKHEITEN</title><author>JACKSON, GRAHAM STUART ; COLLINGE, JOHN ; MCGREGOR, EMMA ; WESTBROOK, JULES ; BYERS, HELEN ; LEEDS, NICOLA LOUISE ; CAMPBELL, JAMES ; WARD, MALCOLM ANDREW</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ATE471519TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>2010</creationdate><toplevel>online_resources</toplevel><creatorcontrib>JACKSON, GRAHAM STUART</creatorcontrib><creatorcontrib>COLLINGE, JOHN</creatorcontrib><creatorcontrib>MCGREGOR, EMMA</creatorcontrib><creatorcontrib>WESTBROOK, JULES</creatorcontrib><creatorcontrib>BYERS, HELEN</creatorcontrib><creatorcontrib>LEEDS, NICOLA LOUISE</creatorcontrib><creatorcontrib>CAMPBELL, JAMES</creatorcontrib><creatorcontrib>WARD, MALCOLM ANDREW</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JACKSON, GRAHAM STUART</au><au>COLLINGE, JOHN</au><au>MCGREGOR, EMMA</au><au>WESTBROOK, JULES</au><au>BYERS, HELEN</au><au>LEEDS, NICOLA LOUISE</au><au>CAMPBELL, JAMES</au><au>WARD, MALCOLM ANDREW</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DIAGNOSE NEURODEGENERATIVER KRANKHEITEN</title><date>2010-07-15</date><risdate>2010</risdate><abstract>The invention relates to a method of diagnosis of vCJD in a diagnostic sample of a valid body tissue taken from a human subject, which comprises detecting an increased concentration of a protein in the diagnostic sample, compared with a sample of a control human subject, the protein being: beta-actin (SwissProt Acc. No. P60709), apolipoprotein A-IV precursor (SwissProt Acc. No. P06727); haptoglobin beta-chain consisting of residues 162-406 (SwissProt Acc. No. P00738); haemoglobin beta chain (SwissProt Acc. No. P02023); or alpha-1-antitrypsin (SwissProt Acc. No. P01009); or a decreased concentration of a protein in the diagnostic sample, compared with a sample of a control, normal human subject, the protein being plasma protease (C1) inhibitor precursor (SwissProt Acc. No. P05155); complement component 1, s sub-component (SwissProt Acc. No. P09871); butyrylcholinesterase precursor (SwissProt Acc. No. P06276); complement component C4B (SwissProt Acc. No. P01028); lumican (SwissProt Acc. No. P51884); alpha-fibrinogen precursor (SwissProt Acc. No. P02671); IGHG4 protein (Swiss Prot Acc. No. Q8TC63) or immunoglobulin lambda heavy chain. Other marker proteins are also disclosed.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | ger |
| recordid | cdi_epo_espacenet_ATE471519TT1 |
| source | esp@cenet |
| title | DIAGNOSE NEURODEGENERATIVER KRANKHEITEN |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T11%3A29%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JACKSON,%20GRAHAM%20STUART&rft.date=2010-07-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EATE471519TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |